This inventor holds 1 USPTO granted patent. Top assignee: Kurume University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Toyojiro Matsuishi: Innovator in Rett Syndrome Treatment
Introduction
Toyojiro Matsuishi is a notable inventor based in Kurume, Japan. He has made significant contributions to the field of medical research, particularly in the treatment of Rett Syndrome (RTT). His innovative approach involves the use of ghrelin, a hormone that plays a role in various physiological processes.
Latest Patents
Matsuishi holds a patent for a method of treating Rett Syndrome, which involves administering ghrelin to a subject in need. This groundbreaking method aims to improve the quality of life for individuals affected by this complex neurological disorder. His patent is a testament to his dedication to advancing medical science and finding effective treatments.
Career Highlights
Matsuishi is affiliated with Kurume University, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential to change the landscape of Rett Syndrome treatment. With 1 patent to his name, he continues to push the boundaries of innovation in medical research.
Collaborations
Matsuishi has worked alongside esteemed colleagues such as Masayasu Kojima and Kotaro Yuge. Their collaborative efforts contribute to the advancement of knowledge and treatment options for Rett Syndrome.
Conclusion
Toyojiro Matsuishi is a pioneering inventor whose work in treating Rett Syndrome with ghrelin showcases his commitment to improving patient outcomes. His contributions to medical research are invaluable and highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile